Skip to main content

Ibrahim Abukhiran, MD

Assistant Professor of Pathology, Director, Leidos Computational Pathology Fellowship, Director, Pathology Image Analysis Laboratory, Associate Director, AI Operations, Computational Pathology and Artificial Intelligence Center of Excellence (CPACE)

Dr. Abukhiran is an Assistant Professor of Gastrointestinal Pathology and Clinical Informatics at the University of Pittsburgh Medical Center and the University of Pittsburgh School of Medicine. He serves as the Associate Director of AI Operations at the Computational Pathology and Artificial Intelligence Center of Excellence (CPACE) and is the Medical Director of the Pathology Image Analysis Laboratory. Additionally, he is the Director of the Computational Pathology/Pathology Informatics Fellowship and the Medical Director of Synoptic Pathology Reporting across UPMC hospitals.

Dr. Abukhiran received his medical degree from the Jordan University of Science and Technology and completed his residency in Anatomic and Clinical Pathology (AP/CP) at the University of Iowa Hospitals and Clinics, where he also pursued a fellowship in Gastrointestinal Surgical Pathology. His clinical and translational research focuses on biomarker immunohistochemistry, digital image analysis, and artificial intelligence, with a particular interest in improving diagnosis, prognostication, and therapy response prediction for inflammatory, pre-malignant, and malignant diseases.

Academic Appointments

  • Associate Director of AI Operations, Computational Pathology and Artificial Intelligence Center of Excellence (CPACE)
  • Director, Computational Pathology/Pathology Informatics Fellowship
  • Medical Director, Pathology Image Analysis Laboratory, University of Pittsburgh Medical Center
  • Medical Director, Synoptic Compliance, University of Pittsburgh Medical Center
  • Medical Director, Resident Education in Gastrointestinal Pathology, University of Pittsburgh Medical Center
  • Assistant Professor, Department of Pathology, University of Pittsburgh School of Medicine
  • Gastrointestinal and Pancreaticobiliary Pathologist, University of Pittsburgh Medical Center - Presbyterian Hospital

Clinical Expertise

Dr. Abukhiran’s diagnostic expertise includes both medical and surgical diseases of the tubal gut, pancreas, biliary tract, and liver.

Specialties

Gastrointestinal (tubal gut) Pathology, Liver Pathology, Pancreaticobiliary Pathology, Diagnostic, Prognostic, and Therapy Predictive Immunohistochemistry, Digital Image Analysis.

Certifications

  • American Board of Medical Specialties, Clinical Informatics, 2024
  • American Board of Medical Specialties, Anatomic Pathology, 2021
  • American Board of Medical Specialties, Clinical Pathology, 2021
  • Educational Commission for Foreign Medical Graduates, Certificate, 2016

Distinctions

  • Outstanding Teaching in Anatomic Pathology, UPMC Pathology Residency, 2024
  • Stowell-Orbison Certificate of Merit, United States and Canadian Academy of Pathology (USCAP,) 2022
  • Stowell-Orbison Certificate of Merit, United States and Canadian Academy of Pathology (USCAP), 2021
  • Association of Indian Pathologists in North America (AIPNA), Best USCAP Abstract Award, 2021
  • Rodger C. Haggitt Gastrointestinal Pathology Society Case of The Month Award, 2021
  • Top 5 Junior Member Abstract Award (4th Place), College of American Pathologists 2020 Annual Meeting, 2020
  • Paul E. Strandjord Young Investigator Award, Academy of Clinical Laboratory Physicians and Scientists (ACLPS), 2020
  • Trainee Pilot Research Award, Department of Pathology, University of Iowa Hospitals and Clinics, 2019
  • Travel Award, National Association of Medical Examiners (NAME), 2018
  • Trainee Pilot Research Award, Department of Pathology, University of Iowa Hospitals and Clinics, 2017
Education & Training
Bachelor of Medicine, Bachelor of Surgery (MBBS), Jordan University of Science and Technology, Irbid, Jordan (2009-2015)
Anatomic & Clinical Pathology Residency (AP/CP), University of Iowa Hospitals and Clinics, Iowa City, Iowa, (2017-2021)
Fellow, Gastrointestinal, liver, and pancreaticobiliary Pathology Fellowship, University of Iowa Hospitals and Clinics, Iowa City, Iowa (2021–2022)
Research Interests

Dr. Abukhiran is a clinical and translational researcher with interest in biomarker immunohistochemistry and digital image analysis. Dr. Abukhiran's main interest is finding novel applications of immunohistochemistry and digital image analysis that serve as diagnostic, prognostic, and predictive of response to therapy.

Representative Publications
  1. Hadjiyannis, Y., Martinez, M. N., Pechacek, J., Abukhiran, I., Riley, D., Pittaluga, S., Morariu, E. M., Lionakis, M. S., Binion, D. G., & Van Deusen, R. (2025). Selective JAK1 inhibition remits multiorgan autoimmunity in a patient with refractory autoimmune polyendocrine syndrome type 1. The Journal of allergy and clinical immunology, S0091-6749(25)00376-8. Advance online publication. https://doi.org/10.1016/j.jaci.2025.03.026
  2. Abukhiran, I. M., Masaadeh, A. H., Byrne, J. D., & Bosch, D. E. (2025). Mucosal microbiome markers of complete pathologic response to neoadjuvant therapy in rectal carcinoma. Cancer research communications, 10.1158/2767-9764.CRC-25-0036. Advance online publication. https://doi.org/10.1158/2767-9764.CRC-25-0036
  3. Abukhiran, I., Neyaz, A., Kop, M., Baroudi, I., Christensen, D., Abdul Baki, M. N., Surakji, H., Shaker, N., Bedell, M. L., Jasser, J., Rammal, R., Deebajah, M., Pai, R., Pantanowitz, L., & Bellizzi, A. (2025). Optimal Approaches to Grading Entero-Pancreatic Neuroendocrine Tumors Using Ki-67 Proliferation Index (Hotspot and Whole Slide Digital Quantitative Analysis). Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 100780. Advance online publication. https://doi.org/10.1016/j.modpat.2025.100780
  4. Anand, S., Gosse, M., Abukhiran, I., Stashek, K., & Bellizzi, A. (2025). Loss of menin detected by immunohistochemistry is reasonably sensitive and very specific for pancreatic origin in a neuroendocrine tumor and distinguishes neuroendocrine tumor from carcinoma. Laboratory Investigation, 105(3).
  5. Baroudi, I., Abukhiran, I., Pai, R. K., & Mansour, A. (2025). Histopathological features of gastrointestinal biopsies following chimeric antigen receptor (CAR) T-cell therapy: A case series. Laboratory Investigation, 105(3).
  6. Bedell, M., Neyaz, A., Pantanowitz, L., Hanna, M., Pearce, T., Rashidi, H., & Abukhiran, I. (2025). Comparison of tumor-infiltrating lymphocyte quantification using AI-based H&E analysis versus CD8 immunohistochemistry across multiple tumor types. Laboratory Investigation, 105(3).
  7. Christensen, D., Bedell, M., Neyaz, A., Rammal, R., Baki, M.-N. A., Noor, Z., & Abukhiran, I. (2025). Predicting histologic grade, T-stage, and risk stratification group of gastrointestinal stromal tumors (GISTs) using digitally quantified tumor cellular density (TCD) from limited tissue samples. Laboratory Investigation, 105(3).
  8. Gonzalez, R., Toro, P., Lacambra, M., Abukhiran, I., Christensen, D., Surakji, H., & Panarelli, N. (2025). Anal adenocarcinomas: Pathologic evaluation of 91 cases demonstrates few clinically relevant differences among subtypes. Laboratory Investigation, 105(3).
  9. Noor, Z., Rammal, R., Seigh, L., Surakji, H., Christensen, D., Baroudi, I., & Abukhiran, I. (2025). Digital Ki-67 quantification of a whole-tumor-section in gastrointestinal stromal tumors (GIST) predicts shorter progression-free survival. Laboratory Investigation, 105(3).
  10. Rashidi, H. H., Pantanowitz, J., Hanna, M., Tafti, A. P., Sanghani, P., Buchinsky, A., & Pearce, T. (2025). Introduction to artificial intelligence and machine learning in pathology and medicine: Generative and nongenerative artificial intelligence basics. Modern Pathology, 38(4), 100688. https://doi.org/10.1016/j.modpat.2024.100688
  11. Shaker, N., Davison, J., Derby, J., Abukhiran, I., Mansour, A., Holtzman, M., & Pai, R. K. (2025). TP53 alterations are an independent adverse prognostic indicator in pseudomyxoma peritonei of appendiceal origin following cytoreductive surgery and intraperitoneal chemotherapy. Applied Immunohistochemistry & Molecular Morphology. https://doi.org/10.1097/PAI.0000000000001245
  12. Surakji, H., Pantanowitz, L., Rashidi, H., Pearce, T., Seigh, L., Baki, M.-N. A., & Abukhiran, I. (2025). Impact of antibody clone and chromogen changes on the quantification of CD8-positive tumor-infiltrating lymphocytes in melanoma: A quantitative imaging analysis study. Laboratory Investigation, 105(3).
  13. Abukhiram, I., Bhagavathi, S., Claassen, D., McLaughlin, H., & Sharathkumar, A. (2024). Congenital neutropenia with specific granulocyte deficiency caused by novel double heterozygous SMARCD2 mutations: Is there a benefit of thrombopoietin receptor agonist therapy? Authorea Preprints.
  14. Baki, M., Abdul, N., Bedell, M., Rammal, R., Shaker, N., Neyaz, A., Wilhelm, A., & Abukhiran, I. (2024). Abnormal p16 expression predicts shorter progression-free survival in gastrointestinal tumors (GISTs). Laboratory Investigation, 2024, S645-S647.
  15. Baki, M., Abdul, N., Shaker, N., Rammal, R., Bedell, M., Neyaz, A., Wilhelm, A., Bellizzi, A., & Abukhiran, I. (2024). Abnormal MTAP expression predicts shorter progression-free survival in gastrointestinal tumors (GISTs). Laboratory Investigation, 2024, S641-S643.
  16. Baki, M., Abdul, N., Bedell, M., Rammal, R., Shaker, N., Neyaz, A., Wilhelm, A., & Abukhiran, I. (2024). Smooth muscle differentiation in gastrointestinal stromal tumors (GISTs) is commonly seen in low stage gastric GISTs, a potential diagnostic pitfall. Laboratory Investigation, 2024, S643-S645.
  17. Bedell, M., Rammal, R., Baki, M., Abdul, N., Shaker, N., Neyaz, A., Wilhelm, A., & Abukhiran, I. (2024). Predictors of progression post adjuvant therapy in gastrointestinal stromal tumors (GISTs): Epithelioid histology and metastasis as the sole predictors, excluding historic grade, or molecular profile. Laboratory Investigation, 2024, S663-S664.
  18. Contrera, K. J., Spector, M. E., Pantanowitz, L., Abukhiran, I., Vujanovic, L., Whiteside, T. L., Mowery, Y. M., Zandberg, D. P., Sriharan, S. S., & Kim, S. (2024). CD8+ tumor-infiltrating lymphocytes in head and neck cancer: A review. JCO Precision Oncology, 8, e2400183. https://doi.org/10.1200/PO.24.00183
  19. Deebajah, M., Fine, J., Abukhiran, I., & Pantanowitz, L. (2024). Enhancing pathological diagnosis for color-blind pathologists through whole slide imaging. Laboratory Investigation, 2024, S1564-S1565.
  20. Fortman, D., Karunamurthy, A., Hartman, D., Wang, H., Seigh, L., Abukhiran, I., Najjar, Y. G., Pantanowitz, L., Zarour, H. M., & Kirkwood, J. M. (2024). Automated quantitative CD8+ tumor-infiltrating lymphocytes and tumor mutation burden as independent biomarkers in melanoma patients receiving front-line anti-PD-1 immunotherapy. The Oncologist, 29(7), 619-628. https://doi.org/10.1093/oncolo/oyae054
  21. Luo, W., Hu, S., Riahi, I., Wang, H., Shaker, N., Abukhiran, I., Wang, T., Polydorides, A., Akinsanya, A., & Gonzalez, I. (2024). Clinicopathologic significance of acellular mucin pools in lymph nodes from untreated colorectal cancer. Laboratory Investigation, 2024, S766-S768.
  22. Memon, R., Polydorides, A., Xu, X., Abukhiran, I., Shaker, N., Lee, H., Subasi, N., Bejarano, P., Bracey, T., & Choi, W.-T. (2024). Primary colorectal squamous cell carcinoma: A multi-institutional series of nineteen cases. Laboratory Investigation, 2024, S774-S775.
  23. Neyaz, A., Abukhiran, I., & Naous, R. (2024). Sporadic NF1-mutated inflammatory polyps of the colon: A case report and brief literature review. Genes, Chromosomes & Cancer, 63(10), e70001. https://doi.org/10.1002/gcc.70001
  24. Nova-Camacho, L., Ma, C., Abukhiran, I., Shaker, N., Collins, K., Gonzalez, I., Chao, T., Yang, Z., Vyas, M., & Bellizzi, A. (2024). Composite gangliocytoma/neuroma and neuroendocrine tumor (CoGNET) of the duodenum: A contemporary clinicopathologic characterization of 61 patients. Laboratory Investigation, 2024, S780-S781.
  25. Pantanowitz, L., Pearce, T., Abukhiran, I., Hanna, M., Wheeler, S., Soong, T. R., Tafti, A. P., Pantanowitz, J., Lu, M. Y., & Mahmood, F. (2024). Non-generative artificial intelligence (AI) in medicine: Advancements and applications in supervised and unsupervised machine learning. Modern Pathology, 2024, 100680. https://doi.org/10.1016/j.modpat.2024.100680
  26. Rammal, R., Bedell, M., Baki, M., Abdul, N., Shaker, N., Neyaz, A., Wilhelm, A., & Abukhiran, I. (2024). A comparative analysis: Ki-67 vs. PHH3 for risk prediction in gastrointestinal stromal tumors (GISTs); higher Ki-67 proliferation index predicts shorter progression-free survival. Laboratory Investigation, 2024, S797-S799.
  27. Sambharia, M., Freese, M. E., Donato, F., Bathla, G., Abukhiran, I., Dantuma, M. I., Mansilla, M. A., & Thomas, C. P. (2024). Suspected autosomal recessive polycystic kidney disease but cerebellar vermis hypoplasia, oligophrenia ataxia, coloboma, and hepatic fibrosis (COACH) syndrome in retrospect, a delayed diagnosis aided by genotyping and reverse phenotyping: A case report and a review of the literature. Nephron, 148(4), 264-272. https://doi.org/10.1159/000527991
  28. Abukhiran, I., & Bellizzi, A. (2023). Alternative lengthening of telomeres (ALT)-positive hepatocellular carcinoma (HCC) occurs exclusively in non-cirrhotic liver, and is associated with nuclear anaplasia, poorly differentiated morphology, and macro-trabecular growth pattern, but not "chromophobic" cytoplasm. Modern Pathology, 36(3), 100123. https://www.webofscience.com/
  29. Abukhiran, I., Eletrebi, M., Masaadeh, A., & Bellizzi, A. (2023). Immunohistochemical characterization of duodenal neuroendocrine tumors, including validation of the novel marker NKX6.2 identified by gene expression profiling. Modern Pathology, 36(3), 100124. https://www.webofscience.com/
  30. Abukhiran, I., Pai, R., & Hartman, D. (2023). GENIE-enhanced digital image analysis increases the diagnostic accuracy of p53 and SATB2 in the diagnosis of inflammatory bowel disease associated dysplasia. Modern Pathology, 36(3), 100125. https://www.webofscience.com/
  31. Abukhiran, I., Rosenthal, N., & Syrbu, S. (2023). Compound angiotrophic biphasic myeloid sarcoma with JAK2 (V617F) and KRAS (G12C) mutations. Moldovan Journal of Health Sciences, 2023(4), 78-80. https://doi.org/10.52645/mjhs.2023.4.10
  32. Callaghan, C. M., Abukhiran, I., Masaadeh, A., Van Rheeden, R. V., Kalen, A. L., Rodman, S. N., & Caster, J. M. (2023). Manipulation of redox metabolism using pharmacologic ascorbate opens a therapeutic window for radio-sensitization by ATM inhibitors in colorectal cancer. International Journal of Radiation Oncology, Biology, Physics, 115(4), 933-944. https://doi.org/10.1016/j.ijrobp.2022.10.012
  33. Choi, A., Abukhiran, I., & Bellizzi, A. (2023). Loss of ATRX/DAXX immunohistochemical expression as a surrogate for alternative lengthening of telomeres (ALT)-positivity is associated with adverse clinicopathologic features in pancreatic neuroendocrine tumors. Modern Pathology, 36(3), 100126. https://www.webofscience.com/
  34. Eletrebi, M., Masaadeh, A., Abukhiran, I., & Bellizzi, A. (2023). PAX1-positivity is specific for an oropharyngeal origin among squamous cell carcinomas. Modern Pathology, 36(3), 100127. https://www.webofscience.com/
  35. Isidro, R. A., Abukhiran, I., Dunseth, C. D., Gosse, M. D., Humble, R. M., Pelletier, D. J., & Hornick, J. L. (2023). Strong annexin A10 expression supports a pancreatic primary and combined annexin A10, claudin 18, and SOX2 expression supports an esophagogastric origin in carcinomas of unknown primary. The American Journal of Surgical Pathology, 47(4), 440-452. https://doi.org/10.1097/PAS.0000000000001994
  36. Rogers, K. J., Abukhiran, I., Syrbu, S., Tomasson, M., Bates, M., Dhakal, P., & Bhagavathi, S. (2023). Utilizing digital pathology and immunohistochemistry of p53 as an adjunct to molecular testing in myeloid disorders. Academic Pathology, 10(1), 100064. https://doi.org/10.1016/j.acpath.2022.100064
  37. Walker, B. J., Lung, M., Lataifeh, H., Patel, A., Abukhiran, I., & Amarneh, M. (2023). The incidence of ischemic cholecystitis after prophylactic cystic artery embolization: A single-center retrospective study. The Arab Journal of Interventional Radiology, 7(2), 88-93. https://doi.org/10.1055/s-0043-1774804
  38. Abukhiran, I., Choi, A., & Bellizzi, A. (2022). Grading gastroenteropancreatic neuroendocrine tumors (GEP-NETs) using clinically validated Ki-67 digital image analysis identifies systematically higher proliferation indices in distant metastases and the superiority of hotspot over whole slide-based quantification. Modern Pathology, 35, 403-405. https://www.webofscience.com/
  39. Caldwell, N., Abukhiran, I., & Bellizzi, A. (2022). Whole-slide digital quantification of intraepithelial gamma/delta T-cell populations can distinguish celiac disease from other etiologies of duodenal intraepithelial lymphocytosis. Modern Pathology, 35, 426-427. https://www.webofscience.com/
  40. Callaghan, C. M., Abukhiran, I., Van Rheeden, R. V., Kalen, A. L., Rodman, S. N., Petronek, M. S., & Caster, J. M. (2022). Pharmacologic ascorbate opens a therapeutic window for ATM inhibition and radiotherapy in colorectal cancer. Cancer Research, 82(12), 2195. https://www.webofscience.com/
  41. Flores, E. M., Abukhiran, I., & Sanchez, A. (2022). Acute on chronic liver disease due to hepatic infiltration of chronic lymphoproliferative disorder of natural killer cells. The American Journal of Gastroenterology, 117(10S), S2096. https://www.webofscience.com/
  42. Isidro, R., Abukhiran, I., Humble, R., Gosse, M., Isaacson, A., Arnouk, J., & Hornick, J. (2022). Evaluation of annexin A10, claudin-18, and SOX2 expression in 545 gastrointestinal and pancreaticobiliary adenocarcinomas. Modern Pathology, 35, 469. https://www.webofscience.com/
  43. Walker, B., Amarneh, M., Patel, A., Lung, M., & Abukhiran, I. (2022). The incidence of ischemic cholecystitis after cystic artery embolization. Journal of Vascular and Interventional Radiology, 33(6), S101. https://doi.org/10.1016/j.jvir.2022.03.300
  44. Abukhiran, I., Farhat, I., Bellizzi, A., & Boukhar, S. (2021). Head-to-head comparison of S-100 and SOX10 in the diagnosis of melanoma. Modern Pathology, 34, 497-498. https://www.webofscience.com/
  45. Abukhiran, I., Farhat, I., Bellizzi, A., & Boukhar, S. (2021). Reduced S-100 expression in melanoma assessed by digital image analysis predicts poor overall survival. Modern Pathology, 34, 284-285. https://www.webofscience.com/
  46. Abukhiran, I., Humble, R., Caldwell, N., Farhat, I., Rajan, A. K. D., Bellizzi, A., & Boukhar, S. (2021). Novel prognostic quantitation of PAX8 expression and tumor-nuclear-size by digital image analysis in renal cell carcinomas; decreased PAX8 expression and higher-tumor-nuclear-size are associated with tumors of larger size, higher grade and stage, and risk of metastasis. Modern Pathology, 34, 521-522. https://www.webofscience.com/
  47. Abukhiran, I., Humble, R., Caldwell, N., Rajan, A. K. D., & Boukhar, S. (2021). SATB2 expression in renal cell carcinoma (RCC) is infrequent and specific for proximal tubular origin. Modern Pathology, 34, 564-565. https://www.webofscience.com/
  48. Abukhiran, I., Jasser, J., & Bhagavathi, S. (2021). Education case: Hereditary thrombophilia with double heterozygous factor V Leiden and factor II c.*97G>A mutations. Academic Pathology, 8, 2374289521990788. https://doi.org/10.1177/2374289521990788
  49. Abukhiran, I., Krasowski, M., Bellizzi, A., Boukhar, S., & Merrill, A. (2021). Patterns and utility of calprotectin in patients with microscopic colitis. American Journal of Clinical Pathology, 156(Suppl 1), S19. https://doi.org/10.1093/ajcp/aqab189.035
  50. Abukhiran, I., Mott, S. L., Bellizzi, A. M., & Boukhar, S. A. (2021). Paraneoplastic leukemoid reaction: Case report and review of the literature. Pathology, Research and Practice, 217, 153295. https://doi.org/10.1016/j.prp.2020.153295
  51. Abukhiran, I., Syrbu, S. I., & Holman, C. J. (2021). Markers of follicular helper T cells are occasionally expressed in T-cell or histiocyte-rich large B-cell lymphoma, classic Hodgkin lymphoma, and atypical paracortical hyperplasia—a diagnostic pitfall for T-cell lymphomas of T follicular helper origin. American Journal of Clinical Pathology, 156(3), 409-426. https://doi.org/10.1093/ajcp/aqaa249
  52. Callaghan, C. M., Abukhiran, I., VanRheeden, R., Ali, M. Y., Petronek, M. S., Mapuskar, K. A., & Caster, J. M. (2021). Pharmacologic ascorbate enhances the therapeutic index of ATM-inhibitor based chemoradiation for colorectal cancer. International Journal of Radiation Oncology, Biology, Physics, 111(3), S56. https://www.webofscience.com/
  53. El-Alali, E. A., Abukhiran, I., & Alhmoud, T. Z. (2021). Successful use of montelukast in eosinophilic gastroenteritis: A case report and a literature review. BMC Gastroenterology, 21(1), 279. https://doi.org/10.1186/s12876-021-01854-x
  54. Gosse, M., Humble, R., Abukhiran, I., & Bellizzi, A. (2021). SMARCA4 (BRG1) loss in upper gastrointestinal adenocarcinoma is not exclusive to tumors with undifferentiated/dedifferentiated/rhabdoid histology. Modern Pathology, 34, 504-505. https://www.webofscience.com/
  55. Abukhiran, I., Bellizzi, A., & Rajan, A. (2020). Characterization of the nuclear phenospace with HALO in Ki-67% proliferation index assessment of gastrointestinal neuroendocrine tumors (GI-NET). Academy of Clinical Laboratory Physicians and Scientists 2020 Annual Meeting. Online.
  56. Abukhiran, I., Bellizzi, A., & Rajan, A. (2020). Detection and classification of organism and organism-like profiles in gastric biopsy Helicobacter immunohistochemistry by digital image analysis (DIA). Modern Pathology, 33, 1435-1436. https://www.webofscience.com/
  57. Abukhiran, I., Gosse, M., Humble, R., & Bellizzi, A. (2020). TTF-1 and napsin A-positivity is rare in gastroesophageal adenocarcinomas: An affirmation. Modern Pathology, 33, 816. https://www.webofscience.com/
  58. Abukhiran, I., Holman, C., & Syrbu, S. (2020). Patterns of expression of PD-1, CXCL13, ICOS, CD10, and BCL-6 in angioimmunoblastic T-cell lymphoma (AITL), peripheral T-cell lymphoma (PTCL), T-cell/histiocyte-rich B-cell lymphoma (TCHRBCL), paracortical hyperplasia, progressive transformation of germinal centers (PTGC), and reactive follicular hyperplasia. Modern Pathology, 33, 1244. https://www.webofscience.com/
  59. Abukhiran, I., Jasser, J., & Bhagavathi, S. (2020). Double-homozygosity for factor V Leiden and prothrombin c.*97G > A mutation in a young female with recurrent fetal losses and no venous thromboembolism. Human Pathology Reports, 22, 200425. https://doi.org/10.1016/j.ehpc.2020.200425
  60. Abukhiran, I., Jasser, J., & Syrbu, S. (2020). Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours. Journal of Clinical Pathology, 73(6), 310-313. https://doi.org/10.1136/jclinpath-2019-206340
  61. Abukhiran, I., Jasser, J., Farhat, I., & Boukhar, S. (2020). Case of a large pedunculated biliary cholesterol polyp with osseous metaplasia. Cureus, 12(12), e12357. https://doi.org/10.7759/cureus.12357
  62. Abukhiran, I., Jasser, J., Hoffman, H. T., & Syrbu, S. (2020). Mantle cell lymphoma involving major and minor salivary glands with parotid sparing. JAMA Otolaryngology—Head & Neck Surgery, 146(3), 309-311. https://doi.org/10.1001/jamaoto.2019.4116
  63. Abukhiran, I., Lora, G. B., Kirby, P., Shelton, J., Shilyanski, J., Wilson, S., & Sato, M. (2020). Inflammatory myofibroblastic tumor mimicking desmoplastic infantile ganglioglioma (DIG) of the temporal lobe. Neuro-Oncology, 22(Suppl 3), 444. https://www.webofscience.com/
  64. Bellizzi, A., Rajan, A., & Abukhiran, I. (2020). Characterization of the nuclear phenospace with HALO in Ki-67 proliferation index assessment of gastrointestinal neuroendocrine tumors. College of American Pathologists 2020 Annual Meeting. Online.
  65. Gosse, M., Humble, R., Abukhiran, I., Hornick, J., & Bellizzi, A. (2020). EBV-positivity is rare in gastroesophageal adenocarcinomas and is restricted to gastric tumors. Modern Pathology, 33, 672-673. https://www.webofscience.com/
  66. Teferi, N., Abukhiran, I., Noeller, J., Helland, L. C., Bathla, G., Ryan, E. C., & Hitchon, P. W. (2020). Vertebral hemangiomas: Diagnosis and management. A single center experience. Clinical Neurology and Neurosurgery, 190, 105745. https://doi.org/10.1016/j.clineuro.2020.105745
  67. Al-Daghmin, A., Alhamss, S., Al-Najjar, H., Al-Saidi, I., Al-Qasem, K., Abukhiran, I., & Alhusban, M. (2019). Survival and metastasis in muscle-invasive bladder cancer patients who present with indeterminate pulmonary nodules before treatment. Annals of Saudi Medicine, 39(1), 42-47. https://doi.org/10.5144/0256-4947.2019.42
  68. Abukhiran, I., & Hefti, M. (2019). Multiple and aggressive vertebral body hemangiomas (VBHs) presenting as metastatic disease: Case report and diagnostic radio-pathological correlation. College of American Pathologists 2019 Annual Meeting. Orlando, FL.
  69. Hasan, Y., Gerke, H., & Abukhiran, I. (2019). Gastrointestinal plasmacytomas. The American Journal of Gastroenterology, 114(Suppl), S1087-S1088. https://doi.org/10.14309/01.ajg.0000597304.82361.8b
  70. Abukhiran, I., Pelletier, D., Bellizzi, A., & Boukhar, S. (2018). Undifferentiated colon cancer presenting with paraneoplastic leukemoid reaction: Case report and literature review. College of American Pathologists 2018 Annual Meeting. Chicago, IL.
  71. Abukhiran, I., Rooney, S., & Firchau, D. (2018). Ketamine intoxication from a topical preparation contributing to heart disease. National Association of Medical Examiners 2018 Annual Meeting. West Palm Beach, FL.
  72. Al Saidi, I. K., Alqasem, K. S., Gharaibeh, S. T., Qamhia, N. Z. N., Abukhiran, I., & Al-Daghmin, A. A. (2017). Trends of partial and radical nephrectomy in managing small renal masses. Turkish Journal of Urology, 43(1), 42-47. https://doi.org/10.5152/tud.2016.33667
  73. Ellati, R. T., Abukhiran, I., Alqasem, K., Jasser, J., Khzouz, J., Bisharat, T., & Al-Daghmin, A. (2017). Clinicopathologic features of translocation renal cell carcinoma. Clinical Genitourinary Cancer, 15(1), 112-116. https://doi.org/10.1016/j.clgc.2016.05.013
  74. Alqasem, K., Abukhiran, I., Jasser, J., Bisharat, T., Ellati, R. T., Khzouz, J., & Al-Daghamin, A. (2016). Clinico-pathological outcomes of post-primary and salvage chemotherapy retroperitoneal lymph node dissection for mixed germ cell tumors, King Hussein Cancer Center experience. Turkish Journal of Urology, 42(4), 256-260. https://doi.org/10.5152/tud.2016.64188